

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of synapse structural plasticity (GO:0051823) | 4.57522989 |
| 2 | adenosine receptor signaling pathway (GO:0001973) | 4.50702929 |
| 3 | synaptic vesicle maturation (GO:0016188) | 4.37380761 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.21735999 |
| 5 | synaptic transmission, dopaminergic (GO:0001963) | 4.17256535 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.15444296 |
| 7 | hemidesmosome assembly (GO:0031581) | 4.14837723 |
| 8 | prepulse inhibition (GO:0060134) | 4.13028162 |
| 9 | desmosome organization (GO:0002934) | 3.86258590 |
| 10 | cell-substrate junction assembly (GO:0007044) | 3.82405791 |
| 11 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.71317805 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.68633554 |
| 13 | central nervous system myelination (GO:0022010) | 3.68038833 |
| 14 | axon ensheathment in central nervous system (GO:0032291) | 3.68038833 |
| 15 | activation of Rac GTPase activity (GO:0032863) | 3.68036230 |
| 16 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.67918463 |
| 17 | barbed-end actin filament capping (GO:0051016) | 3.65646736 |
| 18 | neuromuscular process controlling balance (GO:0050885) | 3.63287828 |
| 19 | adherens junction assembly (GO:0034333) | 3.54342270 |
| 20 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.53687510 |
| 21 | regulation of early endosome to late endosome transport (GO:2000641) | 3.52800460 |
| 22 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.51847132 |
| 23 | mannose metabolic process (GO:0006013) | 3.50118733 |
| 24 | semaphorin-plexin signaling pathway (GO:0071526) | 3.46813146 |
| 25 | focal adhesion assembly (GO:0048041) | 3.46585672 |
| 26 | cell-substrate adherens junction assembly (GO:0007045) | 3.46585672 |
| 27 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.41623254 |
| 28 | auditory behavior (GO:0031223) | 3.40398634 |
| 29 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.38692280 |
| 30 | epithelial cell-cell adhesion (GO:0090136) | 3.36001348 |
| 31 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.35896196 |
| 32 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.35282119 |
| 33 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.34830654 |
| 34 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.34830654 |
| 35 | glycine transport (GO:0015816) | 3.33040095 |
| 36 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.32479369 |
| 37 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.32398748 |
| 38 | vocalization behavior (GO:0071625) | 3.30459724 |
| 39 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.25754176 |
| 40 | positive regulation of receptor recycling (GO:0001921) | 3.23825220 |
| 41 | dendritic spine morphogenesis (GO:0060997) | 3.21584991 |
| 42 | stress fiber assembly (GO:0043149) | 3.19837781 |
| 43 | negative regulation of fatty acid transport (GO:2000192) | 3.17967464 |
| 44 | response to amphetamine (GO:0001975) | 3.17694473 |
| 45 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.17426755 |
| 46 | basement membrane organization (GO:0071711) | 3.17075186 |
| 47 | neuronal action potential propagation (GO:0019227) | 3.16936652 |
| 48 | Golgi transport vesicle coating (GO:0048200) | 3.16137679 |
| 49 | COPI coating of Golgi vesicle (GO:0048205) | 3.16137679 |
| 50 | behavioral response to cocaine (GO:0048148) | 3.16109951 |
| 51 | protein retention in ER lumen (GO:0006621) | 3.13345264 |
| 52 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.07299534 |
| 53 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.06891576 |
| 54 | regulation of extracellular matrix disassembly (GO:0010715) | 3.05608553 |
| 55 | neuronal ion channel clustering (GO:0045161) | 3.05596297 |
| 56 | striatum development (GO:0021756) | 3.05129247 |
| 57 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.02590384 |
| 58 | gamma-aminobutyric acid transport (GO:0015812) | 3.02492496 |
| 59 | regulation of female receptivity (GO:0045924) | 3.01227481 |
| 60 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.00904875 |
| 61 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.99836733 |
| 62 | regulation of glutamate secretion (GO:0014048) | 2.99507993 |
| 63 | skin morphogenesis (GO:0043589) | 2.99226056 |
| 64 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.99027827 |
| 65 | apoptotic process involved in morphogenesis (GO:0060561) | 2.97955212 |
| 66 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.97830973 |
| 67 | dopamine receptor signaling pathway (GO:0007212) | 2.97079543 |
| 68 | regulation of cholesterol homeostasis (GO:2000188) | 2.96392766 |
| 69 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.96322427 |
| 70 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.95746379 |
| 71 | cAMP catabolic process (GO:0006198) | 2.95204974 |
| 72 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.94568178 |
| 73 | synaptic vesicle exocytosis (GO:0016079) | 2.93063743 |
| 74 | endothelial cell chemotaxis (GO:0035767) | 2.91895092 |
| 75 | positive regulation of extracellular matrix organization (GO:1903055) | 2.90742779 |
| 76 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.89946764 |
| 77 | atrioventricular valve morphogenesis (GO:0003181) | 2.88683469 |
| 78 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.88234081 |
| 79 | protein localization to endosome (GO:0036010) | 2.88022760 |
| 80 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.86996467 |
| 81 | regulation of synaptic plasticity (GO:0048167) | 2.85998853 |
| 82 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.85550907 |
| 83 | regulation of ARF GTPase activity (GO:0032312) | 2.85499139 |
| 84 | layer formation in cerebral cortex (GO:0021819) | 2.84240951 |
| 85 | low-density lipoprotein particle clearance (GO:0034383) | 2.83867485 |
| 86 | negative regulation of cell size (GO:0045792) | 2.83615203 |
| 87 | regulation of dendritic spine development (GO:0060998) | 2.83490451 |
| 88 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.82850066 |
| 89 | response to auditory stimulus (GO:0010996) | 2.81611619 |
| 90 | L-amino acid import (GO:0043092) | 2.80782321 |
| 91 | regulation of neurotransmitter uptake (GO:0051580) | 2.80494017 |
| 92 | positive regulation of neurotransmitter transport (GO:0051590) | 2.79916117 |
| 93 | cyclic nucleotide catabolic process (GO:0009214) | 2.79650350 |
| 94 | endocytic recycling (GO:0032456) | 2.78770253 |
| 95 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.78278056 |
| 96 | glutamate secretion (GO:0014047) | 2.78079564 |
| 97 | mating behavior (GO:0007617) | 2.77747857 |
| 98 | regulation of Rap GTPase activity (GO:0032317) | 2.75559415 |
| 99 | peristalsis (GO:0030432) | 2.75363220 |
| 100 | positive regulation of Rap GTPase activity (GO:0032854) | 2.74424063 |
| 101 | adhesion of symbiont to host (GO:0044406) | 2.74245280 |
| 102 | activation of protein kinase A activity (GO:0034199) | 2.74203426 |
| 103 | apoptotic cell clearance (GO:0043277) | 2.72699581 |
| 104 | transmission of nerve impulse (GO:0019226) | 2.72345429 |
| 105 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.72328431 |
| 106 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.72000433 |
| 107 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.70812551 |
| 108 | long-term memory (GO:0007616) | 2.70193887 |
| 109 | neurotransmitter secretion (GO:0007269) | 2.69651512 |
| 110 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.69557823 |
| 111 | virion attachment to host cell (GO:0019062) | 2.67417482 |
| 112 | adhesion of symbiont to host cell (GO:0044650) | 2.67417482 |
| 113 | cell adhesion mediated by integrin (GO:0033627) | 2.66801424 |
| 114 | neuron-neuron synaptic transmission (GO:0007270) | 2.65465277 |
| 115 | response to laminar fluid shear stress (GO:0034616) | 2.63737482 |
| 116 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.63325440 |
| 117 | exploration behavior (GO:0035640) | 2.62596641 |
| 118 | cell-cell junction maintenance (GO:0045217) | 2.62556114 |
| 119 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.62529333 |
| 120 | regulation of postsynaptic membrane potential (GO:0060078) | 2.61930529 |
| 121 | protein heterotrimerization (GO:0070208) | 2.60818592 |
| 122 | cAMP metabolic process (GO:0046058) | 2.60631355 |
| 123 | visual learning (GO:0008542) | 2.60190008 |
| 124 | cell volume homeostasis (GO:0006884) | 2.59981072 |
| 125 | sodium ion export (GO:0071436) | 2.59077034 |
| 126 | axon ensheathment (GO:0008366) | 2.58798683 |
| 127 | ensheathment of neurons (GO:0007272) | 2.58798683 |
| 128 | positive regulation of membrane potential (GO:0045838) | 2.58599431 |
| 129 | endodermal cell differentiation (GO:0035987) | 2.57886281 |
| 130 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.57249891 |
| 131 | renal filtration (GO:0097205) | 2.56782566 |
| 132 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.56694870 |
| 133 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.56694870 |
| 134 | nerve growth factor signaling pathway (GO:0038180) | 2.56008413 |
| 135 | myelination (GO:0042552) | 2.55575102 |
| 136 | regulation of ARF protein signal transduction (GO:0032012) | 2.54331755 |
| 137 | negative regulation of amino acid transport (GO:0051956) | 2.54296461 |
| 138 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.53930354 |
| 139 | regulation of integrin activation (GO:0033623) | 2.53661369 |
| 140 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.53382553 |
| 141 | protein localization to synapse (GO:0035418) | 2.53370436 |
| 142 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.52637384 |
| 143 | neuromuscular process (GO:0050905) | 2.52586776 |
| 144 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.52576901 |
| 145 | actin filament depolymerization (GO:0030042) | 2.51736476 |
| 146 | regulation of extracellular matrix organization (GO:1903053) | 2.50086851 |
| 147 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.50043379 |
| 148 | membrane tubulation (GO:0097320) | 2.49525395 |
| 149 | pinocytosis (GO:0006907) | 2.48552925 |
| 150 | adult walking behavior (GO:0007628) | 2.48176149 |
| 151 | myelin maintenance (GO:0043217) | 2.47868172 |
| 152 | synaptic transmission, glutamatergic (GO:0035249) | 2.47810161 |
| 153 | female mating behavior (GO:0060180) | 2.46701525 |
| 154 | actin filament bundle assembly (GO:0051017) | 2.46122778 |
| 155 | actin filament bundle organization (GO:0061572) | 2.46122778 |
| 156 | positive regulation of protein dephosphorylation (GO:0035307) | 2.46113415 |
| 157 | activation of MAPKKK activity (GO:0000185) | 2.45004180 |
| 158 | long-term synaptic potentiation (GO:0060291) | 2.44984822 |
| 159 | neuromuscular process controlling posture (GO:0050884) | 2.44957141 |
| 160 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.43698670 |
| 161 | protein targeting to plasma membrane (GO:0072661) | 2.43181282 |
| 162 | cellular potassium ion homeostasis (GO:0030007) | 2.42142891 |
| 163 | visual behavior (GO:0007632) | 2.41936627 |
| 164 | positive regulation of fibroblast migration (GO:0010763) | 2.41869415 |
| 165 | endothelial cell morphogenesis (GO:0001886) | 2.40274774 |
| 166 | glutamate receptor signaling pathway (GO:0007215) | 2.40212112 |
| 167 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.39951651 |
| 168 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.38460718 |
| 169 | glucose 6-phosphate metabolic process (GO:0051156) | 2.35687018 |
| 170 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.35144548 |
| 171 | hyaluronan catabolic process (GO:0030214) | 2.34172959 |
| 172 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.33233639 |
| 173 | Rho protein signal transduction (GO:0007266) | 2.31927646 |
| 174 | negative regulation of viral release from host cell (GO:1902187) | 2.31577955 |
| 175 | negative regulation of focal adhesion assembly (GO:0051895) | 2.25597754 |
| 176 | negative regulation of cell junction assembly (GO:1901889) | 2.25597754 |
| 177 | negative regulation of adherens junction organization (GO:1903392) | 2.25597754 |
| 178 | modulation by symbiont of host cellular process (GO:0044068) | 2.22230545 |
| 179 | positive regulation of osteoblast proliferation (GO:0033690) | 2.21872591 |
| 180 | urea cycle (GO:0000050) | 2.20643283 |
| 181 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.20054923 |
| 182 | embryonic process involved in female pregnancy (GO:0060136) | 2.19865374 |
| 183 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.18806473 |
| 184 | hypotonic response (GO:0006971) | 2.18606934 |
| 185 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.18524792 |
| 186 | receptor catabolic process (GO:0032801) | 2.17238333 |
| 187 | positive regulation of histone deacetylation (GO:0031065) | 2.16181810 |
| 188 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.16076164 |
| 189 | positive regulation of protein localization to plasma membrane (GO:1903078) | 2.15772005 |
| 190 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.13991086 |
| 191 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.12273344 |
| 192 | positive regulation of pseudopodium assembly (GO:0031274) | 2.12167410 |
| 193 | fibril organization (GO:0097435) | 2.11606297 |
| 194 | activation of JUN kinase activity (GO:0007257) | 2.11437962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.92806274 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.58655399 |
| 3 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.50505135 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.47766382 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.45477182 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.42359305 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.37327074 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.35835562 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.31148856 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.31148856 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.24305468 |
| 12 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.20093648 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.19620438 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.16242255 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.11627656 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.10551068 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10331333 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.09561293 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07877532 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.07620905 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.91053917 |
| 22 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85938104 |
| 23 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.82063253 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.81587968 |
| 25 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.80265041 |
| 26 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77051190 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76803028 |
| 28 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.75893102 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.74376110 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.74337110 |
| 31 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.73543620 |
| 32 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.72222991 |
| 33 | KDM2B_26808549_Chip-Seq_K562_Human | 1.71988776 |
| 34 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.71889564 |
| 35 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.71214975 |
| 36 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.71014182 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67766101 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.67749361 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66353576 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.64006311 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62434845 |
| 42 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.61744556 |
| 43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.60150814 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.60059886 |
| 45 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.59707019 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55698885 |
| 47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.55018858 |
| 48 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.54527230 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54145288 |
| 50 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.51780424 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.49165534 |
| 52 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46427197 |
| 53 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.45201384 |
| 54 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.42413832 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.41381676 |
| 56 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.41043616 |
| 57 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.40366097 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39264055 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.38577893 |
| 60 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35888247 |
| 61 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.35563638 |
| 62 | ATF3_27146783_Chip-Seq_COLON_Human | 1.35390902 |
| 63 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.33679294 |
| 64 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.32971784 |
| 65 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32949236 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31339408 |
| 67 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30388483 |
| 68 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.30166094 |
| 69 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.30030017 |
| 70 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.28229561 |
| 71 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.27044569 |
| 72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.25100574 |
| 73 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.24827590 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24361569 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23076679 |
| 76 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21528345 |
| 77 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20534163 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19605243 |
| 79 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.18632538 |
| 80 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18524587 |
| 81 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.16991440 |
| 82 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16213896 |
| 83 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.16105367 |
| 84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.15895784 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15203776 |
| 86 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15183904 |
| 87 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15013747 |
| 88 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13402636 |
| 89 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13110224 |
| 90 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13101240 |
| 91 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12902187 |
| 92 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11975466 |
| 93 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11631192 |
| 94 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.10632452 |
| 95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10606286 |
| 96 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10398005 |
| 97 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09563271 |
| 98 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09563271 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09353724 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09050498 |
| 101 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08792799 |
| 102 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08014145 |
| 103 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07463201 |
| 104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06448911 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05746665 |
| 106 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.05730380 |
| 107 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04563819 |
| 108 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04490849 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04460350 |
| 110 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.03976309 |
| 111 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03700881 |
| 112 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03441010 |
| 113 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02921838 |
| 114 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02230718 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01390169 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00447303 |
| 117 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00196330 |
| 118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99747375 |
| 119 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99219177 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99061024 |
| 121 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.98536085 |
| 122 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98382666 |
| 123 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98265080 |
| 124 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97818755 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97534948 |
| 126 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97465927 |
| 127 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97465927 |
| 128 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.96689133 |
| 129 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96250334 |
| 130 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93437367 |
| 131 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93390944 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92615428 |
| 133 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91986540 |
| 134 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91703242 |
| 135 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91030231 |
| 136 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90639618 |
| 137 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90200498 |
| 138 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89251521 |
| 139 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88746987 |
| 140 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88327419 |
| 141 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88316117 |
| 142 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88306735 |
| 143 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88306735 |
| 144 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86337730 |
| 145 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85827581 |
| 146 | AR_19668381_ChIP-Seq_PC3_Human | 0.85794686 |
| 147 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84711810 |
| 148 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.84346633 |
| 149 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.84092830 |
| 150 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.83744911 |
| 151 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.83155871 |
| 152 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.82300558 |
| 153 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81873212 |
| 154 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81733657 |
| 155 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81112736 |
| 156 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80915729 |
| 157 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.80465971 |
| 158 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.80006236 |
| 159 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.79756289 |
| 160 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.79342449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 7.29995252 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.92696441 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.22961583 |
| 4 | MP0003880_abnormal_central_pattern | 2.93292877 |
| 5 | MP0003566_abnormal_cell_adhesion | 2.93015284 |
| 6 | MP0009745_abnormal_behavioral_response | 2.86786418 |
| 7 | MP0004270_analgesia | 2.84092619 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.63458346 |
| 9 | MP0002064_seizures | 2.51177023 |
| 10 | MP0003329_amyloid_beta_deposits | 2.48295369 |
| 11 | MP0001849_ear_inflammation | 2.46694425 |
| 12 | MP0000920_abnormal_myelination | 2.45784620 |
| 13 | MP0004272_abnormal_basement_membrane | 2.35535216 |
| 14 | MP0005076_abnormal_cell_differentiation | 2.25431509 |
| 15 | MP0001486_abnormal_startle_reflex | 2.17528921 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.17381809 |
| 17 | MP0003690_abnormal_glial_cell | 2.13777711 |
| 18 | MP0005451_abnormal_body_composition | 2.09607437 |
| 19 | MP0005257_abnormal_intraocular_pressure | 2.08700463 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 2.07538663 |
| 21 | MP0003075_altered_response_to | 2.05226700 |
| 22 | MP0009046_muscle_twitch | 2.01414861 |
| 23 | MP0002272_abnormal_nervous_system | 2.00667822 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 1.96844358 |
| 25 | MP0005623_abnormal_meninges_morphology | 1.86622102 |
| 26 | MP0005670_abnormal_white_adipose | 1.85462014 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 1.81465505 |
| 28 | MP0000604_amyloidosis | 1.69657221 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.68656674 |
| 30 | MP0005666_abnormal_adipose_tissue | 1.67899229 |
| 31 | MP0002060_abnormal_skin_morphology | 1.66266107 |
| 32 | MP0001529_abnormal_vocalization | 1.63737479 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.62865548 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.60897409 |
| 35 | MP0008569_lethality_at_weaning | 1.60368663 |
| 36 | MP0008260_abnormal_autophagy | 1.58317479 |
| 37 | MP0008874_decreased_physiological_sensi | 1.56893475 |
| 38 | MP0005423_abnormal_somatic_nervous | 1.56452918 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.51887993 |
| 40 | MP0004885_abnormal_endolymph | 1.51598644 |
| 41 | MP0004947_skin_inflammation | 1.49633359 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.49615932 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.47549529 |
| 44 | MP0003633_abnormal_nervous_system | 1.45909752 |
| 45 | MP0000858_altered_metastatic_potential | 1.44956324 |
| 46 | MP0001968_abnormal_touch/_nociception | 1.44474967 |
| 47 | MP0010368_abnormal_lymphatic_system | 1.42088054 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.39403369 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.39283614 |
| 50 | MP0002139_abnormal_hepatobiliary_system | 1.36101243 |
| 51 | MP0002734_abnormal_mechanical_nocicepti | 1.33100863 |
| 52 | MP0000767_abnormal_smooth_muscle | 1.32482627 |
| 53 | MP0009840_abnormal_foam_cell | 1.31637041 |
| 54 | MP0004811_abnormal_neuron_physiology | 1.31183038 |
| 55 | MP0001177_atelectasis | 1.29176073 |
| 56 | MP0005501_abnormal_skin_physiology | 1.28787424 |
| 57 | MP0005409_darkened_coat_color | 1.28502110 |
| 58 | MP0001348_abnormal_lacrimal_gland | 1.28339515 |
| 59 | MP0003436_decreased_susceptibility_to | 1.28205339 |
| 60 | MP0002089_abnormal_postnatal_growth/wei | 1.26596295 |
| 61 | MP0001970_abnormal_pain_threshold | 1.26459115 |
| 62 | MP0004858_abnormal_nervous_system | 1.24940312 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.23280240 |
| 64 | MP0003631_nervous_system_phenotype | 1.22218304 |
| 65 | MP0003634_abnormal_glial_cell | 1.21677013 |
| 66 | MP0004924_abnormal_behavior | 1.20819626 |
| 67 | MP0005386_behavior/neurological_phenoty | 1.20819626 |
| 68 | MP0002733_abnormal_thermal_nociception | 1.20093583 |
| 69 | MP0003091_abnormal_cell_migration | 1.19548059 |
| 70 | MP0001440_abnormal_grooming_behavior | 1.18464573 |
| 71 | MP0002896_abnormal_bone_mineralization | 1.13355262 |
| 72 | MP0000678_abnormal_parathyroid_gland | 1.11016051 |
| 73 | MP0000751_myopathy | 1.10525442 |
| 74 | MP0002090_abnormal_vision | 1.09642613 |
| 75 | MP0000733_abnormal_muscle_development | 1.09015987 |
| 76 | MP0006138_congestive_heart_failure | 1.08795030 |
| 77 | MP0005595_abnormal_vascular_smooth | 1.08220393 |
| 78 | MP0005275_abnormal_skin_tensile | 1.07264023 |
| 79 | MP0000003_abnormal_adipose_tissue | 1.04865256 |
| 80 | MP0000579_abnormal_nail_morphology | 1.04443698 |
| 81 | MP0002066_abnormal_motor_capabilities/c | 1.04186216 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 1.03767880 |
| 83 | MP0000467_abnormal_esophagus_morphology | 1.03265008 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 1.02777427 |
| 85 | MP0000955_abnormal_spinal_cord | 1.02144381 |
| 86 | MP0001216_abnormal_epidermal_layer | 1.02001605 |
| 87 | MP0010678_abnormal_skin_adnexa | 1.01283574 |
| 88 | MP0003300_gastrointestinal_ulcer | 0.98761534 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.98036840 |
| 90 | MP0002254_reproductive_system_inflammat | 0.97850620 |
| 91 | MP0003303_peritoneal_inflammation | 0.96879726 |
| 92 | MP0003632_abnormal_nervous_system | 0.96432347 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.95955128 |
| 94 | MP0003879_abnormal_hair_cell | 0.95381183 |
| 95 | MP0003448_altered_tumor_morphology | 0.95290321 |
| 96 | MP0000537_abnormal_urethra_morphology | 0.94816397 |
| 97 | MP0000747_muscle_weakness | 0.94363641 |
| 98 | MP0005503_abnormal_tendon_morphology | 0.94275825 |
| 99 | MP0003172_abnormal_lysosome_physiology | 0.94079028 |
| 100 | MP0001533_abnormal_skeleton_physiology | 0.93395372 |
| 101 | MP0008872_abnormal_physiological_respon | 0.92705041 |
| 102 | MP0009384_cardiac_valve_regurgitation | 0.92695441 |
| 103 | MP0005508_abnormal_skeleton_morphology | 0.91302947 |
| 104 | MP0002249_abnormal_larynx_morphology | 0.91123243 |
| 105 | MP0005646_abnormal_pituitary_gland | 0.90483343 |
| 106 | MP0001243_abnormal_dermal_layer | 0.88959783 |
| 107 | MP0010030_abnormal_orbit_morphology | 0.88908726 |
| 108 | MP0002933_joint_inflammation | 0.88179900 |
| 109 | MP0000249_abnormal_blood_vessel | 0.88010780 |
| 110 | MP0005165_increased_susceptibility_to | 0.87398356 |
| 111 | MP0010155_abnormal_intestine_physiology | 0.86701870 |
| 112 | MP0003045_fibrosis | 0.86418257 |
| 113 | MP0003828_pulmonary_edema | 0.86315757 |
| 114 | MP0001346_abnormal_lacrimal_gland | 0.86187225 |
| 115 | MP0009278_abnormal_bone_marrow | 0.86075535 |
| 116 | MP0002736_abnormal_nociception_after | 0.85372212 |
| 117 | MP0000343_altered_response_to | 0.85364327 |
| 118 | MP0001905_abnormal_dopamine_level | 0.84328269 |
| 119 | MP0001958_emphysema | 0.83486790 |
| 120 | MP0002882_abnormal_neuron_morphology | 0.83382526 |
| 121 | MP0003283_abnormal_digestive_organ | 0.83278961 |
| 122 | MP0005058_abnormal_lysosome_morphology | 0.83041656 |
| 123 | MP0005390_skeleton_phenotype | 0.82517988 |
| 124 | MP0008004_abnormal_stomach_pH | 0.82487774 |
| 125 | MP0005621_abnormal_cell_physiology | 0.82152259 |
| 126 | MP0005166_decreased_susceptibility_to | 0.81613107 |
| 127 | MP0005360_urolithiasis | 0.80916238 |
| 128 | MP0002557_abnormal_social/conspecific_i | 0.79959594 |
| 129 | MP0009931_abnormal_skin_appearance | 0.79430069 |
| 130 | MP0002067_abnormal_sensory_capabilities | 0.79212906 |
| 131 | MP0004085_abnormal_heartbeat | 0.76820144 |
| 132 | MP0004510_myositis | 0.75739092 |
| 133 | MP0003183_abnormal_peptide_metabolism | 0.75566024 |
| 134 | MP0002796_impaired_skin_barrier | 0.75248864 |
| 135 | MP0005164_abnormal_response_to | 0.74781805 |
| 136 | MP0010771_integument_phenotype | 0.74074925 |
| 137 | MP0002098_abnormal_vibrissa_morphology | 0.74065499 |
| 138 | MP0004142_abnormal_muscle_tone | 0.73909847 |
| 139 | MP0002295_abnormal_pulmonary_circulatio | 0.72597518 |
| 140 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72413999 |
| 141 | MP0001299_abnormal_eye_distance/ | 0.72307958 |
| 142 | MP0002971_abnormal_brown_adipose | 0.72253776 |
| 143 | MP0003279_aneurysm | 0.71782325 |
| 144 | MP0000759_abnormal_skeletal_muscle | 0.71717653 |
| 145 | MP0000762_abnormal_tongue_morphology | 0.69577480 |
| 146 | MP0002970_abnormal_white_adipose | 0.69368041 |
| 147 | MP0003195_calcinosis | 0.69214129 |
| 148 | MP0010329_abnormal_lipoprotein_level | 0.69093139 |
| 149 | MP0002229_neurodegeneration | 0.69010380 |
| 150 | MP0003453_abnormal_keratinocyte_physiol | 0.68646397 |
| 151 | MP0000462_abnormal_digestive_system | 0.68416607 |
| 152 | MP0002069_abnormal_eating/drinking_beha | 0.68138572 |
| 153 | MP0002118_abnormal_lipid_homeostasis | 0.68135120 |
| 154 | MP0001542_abnormal_bone_strength | 0.68043723 |
| 155 | MP0005365_abnormal_bile_salt | 0.67921912 |
| 156 | MP0005535_abnormal_body_temperature | 0.67794204 |
| 157 | MP0000778_abnormal_nervous_system | 0.67470147 |
| 158 | MP0000566_synostosis | 0.66671949 |
| 159 | MP0005375_adipose_tissue_phenotype | 0.65121312 |
| 160 | MP0004185_abnormal_adipocyte_glucose | 0.65032607 |
| 161 | MP0004130_abnormal_muscle_cell | 0.64503128 |
| 162 | MP0005023_abnormal_wound_healing | 0.64432392 |
| 163 | MP0000569_abnormal_digit_pigmentation | 0.63829489 |
| 164 | MP0003950_abnormal_plasma_membrane | 0.62295910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.73014243 |
| 2 | Focal motor seizures (HP:0011153) | 4.30788290 |
| 3 | Neurofibrillary tangles (HP:0002185) | 3.97166226 |
| 4 | Torticollis (HP:0000473) | 3.74683048 |
| 5 | Focal seizures (HP:0007359) | 3.70982217 |
| 6 | Cerebral inclusion bodies (HP:0100314) | 3.55414370 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 3.44191295 |
| 8 | Action tremor (HP:0002345) | 3.42629668 |
| 9 | Resting tremor (HP:0002322) | 3.29068622 |
| 10 | Ankle clonus (HP:0011448) | 3.24780097 |
| 11 | Broad face (HP:0000283) | 3.23964835 |
| 12 | Cervical subluxation (HP:0003308) | 3.19504082 |
| 13 | Annular pancreas (HP:0001734) | 3.12784676 |
| 14 | Hyperacusis (HP:0010780) | 3.12181476 |
| 15 | Craniofacial dystonia (HP:0012179) | 3.11741898 |
| 16 | Increased connective tissue (HP:0009025) | 3.11018150 |
| 17 | Fragile skin (HP:0001030) | 3.10022856 |
| 18 | Focal dystonia (HP:0004373) | 3.08908154 |
| 19 | Premature rupture of membranes (HP:0001788) | 3.04608456 |
| 20 | Dysmetria (HP:0001310) | 2.98842277 |
| 21 | Vertebral compression fractures (HP:0002953) | 2.93942295 |
| 22 | Thin bony cortex (HP:0002753) | 2.93622797 |
| 23 | Obstructive sleep apnea (HP:0002870) | 2.83548407 |
| 24 | Achilles tendon contracture (HP:0001771) | 2.83137888 |
| 25 | Intention tremor (HP:0002080) | 2.83047718 |
| 26 | Abnormality of the Achilles tendon (HP:0005109) | 2.79872254 |
| 27 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.75033512 |
| 28 | Abnormal social behavior (HP:0012433) | 2.68811105 |
| 29 | Impaired social interactions (HP:0000735) | 2.68811105 |
| 30 | Hemorrhage of the eye (HP:0011885) | 2.64485900 |
| 31 | Poor eye contact (HP:0000817) | 2.63754579 |
| 32 | Spastic gait (HP:0002064) | 2.63614193 |
| 33 | Dysdiadochokinesis (HP:0002075) | 2.62658294 |
| 34 | Insidious onset (HP:0003587) | 2.62395318 |
| 35 | Termporal pattern (HP:0011008) | 2.62395318 |
| 36 | Distal lower limb muscle weakness (HP:0009053) | 2.60965455 |
| 37 | Protrusio acetabuli (HP:0003179) | 2.60226580 |
| 38 | Deep venous thrombosis (HP:0002625) | 2.60122996 |
| 39 | Turricephaly (HP:0000262) | 2.59926386 |
| 40 | Scanning speech (HP:0002168) | 2.58810179 |
| 41 | Ankyloglossia (HP:0010296) | 2.57584309 |
| 42 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.57315993 |
| 43 | Urinary urgency (HP:0000012) | 2.56854312 |
| 44 | Postural instability (HP:0002172) | 2.52367480 |
| 45 | * Onion bulb formation (HP:0003383) | 2.51344495 |
| 46 | Spinal rigidity (HP:0003306) | 2.50509468 |
| 47 | Anxiety (HP:0000739) | 2.48676151 |
| 48 | Arterial tortuosity (HP:0005116) | 2.48102655 |
| 49 | Ulnar bowing (HP:0003031) | 2.47311388 |
| 50 | Vascular tortuosity (HP:0004948) | 2.46551049 |
| 51 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.43070761 |
| 52 | Polygenic inheritance (HP:0010982) | 2.42848811 |
| 53 | Nuclear cataract (HP:0100018) | 2.41414918 |
| 54 | J-shaped sella turcica (HP:0002680) | 2.39767281 |
| 55 | Aortic aneurysm (HP:0004942) | 2.39476215 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.38815570 |
| 57 | Depression (HP:0000716) | 2.37181776 |
| 58 | Atrioventricular block (HP:0001678) | 2.34057661 |
| 59 | Stridor (HP:0010307) | 2.32645916 |
| 60 | Abnormality of the periventricular white matter (HP:0002518) | 2.28731015 |
| 61 | Wormian bones (HP:0002645) | 2.28362431 |
| 62 | Aplasia involving bones of the extremities (HP:0009825) | 2.28197796 |
| 63 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.28197796 |
| 64 | Aplasia of the phalanges of the hand (HP:0009802) | 2.28197796 |
| 65 | Aneurysm (HP:0002617) | 2.26139316 |
| 66 | Hyporeflexia of lower limbs (HP:0002600) | 2.26133882 |
| 67 | Megalencephaly (HP:0001355) | 2.25777113 |
| 68 | Increased variability in muscle fiber diameter (HP:0003557) | 2.25612342 |
| 69 | Aortic dissection (HP:0002647) | 2.25404311 |
| 70 | Neuronal loss in central nervous system (HP:0002529) | 2.25130158 |
| 71 | Mitral regurgitation (HP:0001653) | 2.23219524 |
| 72 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.21643347 |
| 73 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.21643347 |
| 74 | Pointed chin (HP:0000307) | 2.21623072 |
| 75 | Flat acetabular roof (HP:0003180) | 2.21414413 |
| 76 | Ankle contracture (HP:0006466) | 2.21137814 |
| 77 | Broad metatarsal (HP:0001783) | 2.20260136 |
| 78 | Abnormality of oral frenula (HP:0000190) | 2.19450078 |
| 79 | Peritonitis (HP:0002586) | 2.18539813 |
| 80 | Dysmetric saccades (HP:0000641) | 2.18225334 |
| 81 | Osteolytic defects of the hand bones (HP:0009699) | 2.15707157 |
| 82 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.15707157 |
| 83 | Spastic tetraparesis (HP:0001285) | 2.15004540 |
| 84 | Short nail (HP:0001799) | 2.13852661 |
| 85 | Disproportionate tall stature (HP:0001519) | 2.13823363 |
| 86 | Bladder diverticulum (HP:0000015) | 2.13744518 |
| 87 | Amyloidosis (HP:0011034) | 2.13582035 |
| 88 | Mucopolysacchariduria (HP:0008155) | 2.13061780 |
| 89 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13061780 |
| 90 | Malnutrition (HP:0004395) | 2.13012226 |
| 91 | Shallow orbits (HP:0000586) | 2.12599601 |
| 92 | Blue sclerae (HP:0000592) | 2.11938261 |
| 93 | Difficulty running (HP:0009046) | 2.11548274 |
| 94 | Clonus (HP:0002169) | 2.08976824 |
| 95 | Rapidly progressive (HP:0003678) | 2.08741553 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 2.08014221 |
| 97 | Difficulty climbing stairs (HP:0003551) | 2.07654748 |
| 98 | Spondylolisthesis (HP:0003302) | 2.07649977 |
| 99 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07520645 |
| 100 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07520645 |
| 101 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07520645 |
| 102 | Generalized tonic-clonic seizures (HP:0002069) | 2.06306962 |
| 103 | Lower limb muscle weakness (HP:0007340) | 2.04585074 |
| 104 | Abnormality of the corticospinal tract (HP:0002492) | 2.02925067 |
| 105 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.02732825 |
| 106 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.02732825 |
| 107 | Abnormality of glycolipid metabolism (HP:0010969) | 2.02732825 |
| 108 | Abnormal atrioventricular conduction (HP:0005150) | 2.02407015 |
| 109 | Bronchomalacia (HP:0002780) | 2.01630092 |
| 110 | Visual hallucinations (HP:0002367) | 2.00704517 |
| 111 | Peripheral hypomyelination (HP:0007182) | 1.99465367 |
| 112 | Hemiplegia (HP:0002301) | 1.99169062 |
| 113 | Heart block (HP:0012722) | 1.98561525 |
| 114 | Joint stiffness (HP:0001387) | 1.98294261 |
| 115 | Abnormality of complement system (HP:0005339) | 1.97636903 |
| 116 | Xanthomatosis (HP:0000991) | 1.97109141 |
| 117 | Cerebral aneurysm (HP:0004944) | 1.96774118 |
| 118 | Stereotypic behavior (HP:0000733) | 1.96192174 |
| 119 | Abnormality of the lower motor neuron (HP:0002366) | 1.94868341 |
| 120 | Generalized amyotrophy (HP:0003700) | 1.94452508 |
| 121 | Hand muscle atrophy (HP:0009130) | 1.93156922 |
| 122 | Milia (HP:0001056) | 1.91909441 |
| 123 | Acanthosis nigricans (HP:0000956) | 1.91584776 |
| 124 | Hypertriglyceridemia (HP:0002155) | 1.89738639 |
| 125 | Myocardial infarction (HP:0001658) | 1.88211071 |
| 126 | Epileptic encephalopathy (HP:0200134) | 1.87850596 |
| 127 | Dilatation of the ascending aorta (HP:0005111) | 1.87123165 |
| 128 | Abnormality of saccadic eye movements (HP:0000570) | 1.85970957 |
| 129 | * Distal upper limb amyotrophy (HP:0007149) | 1.85840735 |
| 130 | * Upper limb amyotrophy (HP:0009129) | 1.85840735 |
| 131 | Atrophic scars (HP:0001075) | 1.85065754 |
| 132 | Slow saccadic eye movements (HP:0000514) | 1.84341345 |
| 133 | Insomnia (HP:0100785) | 1.84181057 |
| 134 | Broad-based gait (HP:0002136) | 1.82590165 |
| 135 | Biconcave vertebral bodies (HP:0004586) | 1.82304965 |
| 136 | Buphthalmos (HP:0000557) | 1.81887262 |
| 137 | Infantile muscular hypotonia (HP:0008947) | 1.81639646 |
| 138 | Aortic regurgitation (HP:0001659) | 1.81316029 |
| 139 | Genu recurvatum (HP:0002816) | 1.81290346 |
| 140 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.80802941 |
| 141 | Impaired vibratory sensation (HP:0002495) | 1.79772402 |
| 142 | Gaze-evoked nystagmus (HP:0000640) | 1.78457662 |
| 143 | Coxa vara (HP:0002812) | 1.78137206 |
| 144 | Increased cerebral lipofuscin (HP:0011813) | 1.78109205 |
| 145 | Natal tooth (HP:0000695) | 1.77888478 |
| 146 | Mitral valve prolapse (HP:0001634) | 1.77430149 |
| 147 | Right ventricular cardiomyopathy (HP:0011663) | 1.77224489 |
| 148 | Hyperparathyroidism (HP:0000843) | 1.76983658 |
| 149 | Elbow flexion contracture (HP:0002987) | 1.75929991 |
| 150 | Advanced eruption of teeth (HP:0006288) | 1.75891098 |
| 151 | Easy fatigability (HP:0003388) | 1.75457035 |
| 152 | Abdominal distention (HP:0003270) | 1.75100239 |
| 153 | Rigidity (HP:0002063) | 1.74310370 |
| 154 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.74289762 |
| 155 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.74040566 |
| 156 | Interstitial pulmonary disease (HP:0006530) | 1.73932017 |
| 157 | Prolonged QT interval (HP:0001657) | 1.72225881 |
| 158 | Hyperlipoproteinemia (HP:0010980) | 1.71953170 |
| 159 | Papilledema (HP:0001085) | 1.71203216 |
| 160 | Sensory axonal neuropathy (HP:0003390) | 1.70264576 |
| 161 | * Distal lower limb amyotrophy (HP:0008944) | 1.70250989 |
| 162 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.70066534 |
| 163 | Dialeptic seizures (HP:0011146) | 1.69615268 |
| 164 | Scapular winging (HP:0003691) | 1.69334525 |
| 165 | Lymphangioma (HP:0100764) | 1.68450544 |
| 166 | Status epilepticus (HP:0002133) | 1.67690357 |
| 167 | Bone pain (HP:0002653) | 1.66924729 |
| 168 | Abnormal eating behavior (HP:0100738) | 1.66493187 |
| 169 | Trismus (HP:0000211) | 1.66225277 |
| 170 | Slow progression (HP:0003677) | 1.66223309 |
| 171 | Spinal cord compression (HP:0002176) | 1.66196219 |
| 172 | Bowel incontinence (HP:0002607) | 1.65760711 |
| 173 | Absence seizures (HP:0002121) | 1.65634996 |
| 174 | Bradykinesia (HP:0002067) | 1.64943429 |
| 175 | Bundle branch block (HP:0011710) | 1.63399029 |
| 176 | Menorrhagia (HP:0000132) | 1.60514339 |
| 177 | Abnormality of the acetabulum (HP:0003170) | 1.60425923 |
| 178 | Joint laxity (HP:0001388) | 1.60322859 |
| 179 | Abnormal ossification of hand bones (HP:0005921) | 1.60256444 |
| 180 | Neonatal death (HP:0003811) | 1.59477670 |
| 181 | Long palpebral fissure (HP:0000637) | 1.59368180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.26917302 |
| 2 | MST1R | 4.00284420 |
| 3 | EPHA2 | 3.96965464 |
| 4 | IRAK3 | 2.88588581 |
| 5 | MAP3K9 | 2.76550005 |
| 6 | KSR2 | 2.70508101 |
| 7 | NTRK3 | 2.58468428 |
| 8 | PRKD3 | 2.56683798 |
| 9 | DAPK2 | 2.50799226 |
| 10 | MAP3K13 | 2.32588854 |
| 11 | TRIB3 | 2.27587480 |
| 12 | NTRK1 | 2.27109458 |
| 13 | RIPK4 | 2.06496060 |
| 14 | LMTK2 | 2.05524660 |
| 15 | CAMKK1 | 2.02795049 |
| 16 | PAK6 | 2.02331255 |
| 17 | SMG1 | 1.99641790 |
| 18 | NME2 | 1.75588577 |
| 19 | TYRO3 | 1.66812761 |
| 20 | TAOK1 | 1.65604806 |
| 21 | TESK1 | 1.64056398 |
| 22 | FES | 1.59221186 |
| 23 | EPHB1 | 1.58040965 |
| 24 | PAK4 | 1.56522087 |
| 25 | MAP3K2 | 1.46840739 |
| 26 | BMX | 1.41736700 |
| 27 | ARAF | 1.41077868 |
| 28 | CDK5 | 1.38988048 |
| 29 | FGFR4 | 1.34627526 |
| 30 | EEF2K | 1.34390551 |
| 31 | DDR2 | 1.30225382 |
| 32 | STK39 | 1.28493404 |
| 33 | CDK12 | 1.27144659 |
| 34 | SIK2 | 1.26355009 |
| 35 | MINK1 | 1.25305700 |
| 36 | EPHB2 | 1.24874506 |
| 37 | RIPK1 | 1.24476341 |
| 38 | TAOK2 | 1.23448142 |
| 39 | PRKCH | 1.23365314 |
| 40 | MARK2 | 1.21373165 |
| 41 | MAP3K3 | 1.21231214 |
| 42 | PTK2B | 1.20952555 |
| 43 | PDGFRA | 1.14694464 |
| 44 | PDPK1 | 1.11184899 |
| 45 | MAP3K11 | 1.07489540 |
| 46 | MAP2K3 | 1.04411038 |
| 47 | MOS | 1.03888461 |
| 48 | PRPF4B | 1.03515336 |
| 49 | RET | 1.02776332 |
| 50 | NTRK2 | 1.02624225 |
| 51 | PRKG2 | 1.02506797 |
| 52 | TTN | 1.00669381 |
| 53 | OXSR1 | 0.98055709 |
| 54 | MTOR | 0.97957852 |
| 55 | WNK1 | 0.94887070 |
| 56 | DMPK | 0.94869071 |
| 57 | MAP3K7 | 0.94153091 |
| 58 | ALK | 0.92294951 |
| 59 | FGFR2 | 0.92280214 |
| 60 | STK38 | 0.89662887 |
| 61 | CAMK2B | 0.89259211 |
| 62 | SGK223 | 0.87769113 |
| 63 | SGK494 | 0.87769113 |
| 64 | TBK1 | 0.87480760 |
| 65 | MAP3K1 | 0.87263229 |
| 66 | PRKD2 | 0.86598741 |
| 67 | DAPK3 | 0.86474652 |
| 68 | ICK | 0.85011792 |
| 69 | ERN1 | 0.84945808 |
| 70 | CDK15 | 0.84071057 |
| 71 | KSR1 | 0.82196801 |
| 72 | PDK1 | 0.82033992 |
| 73 | STK11 | 0.81518248 |
| 74 | RAF1 | 0.80453757 |
| 75 | RPS6KA2 | 0.80171573 |
| 76 | TGFBR2 | 0.79458877 |
| 77 | MYLK | 0.79159832 |
| 78 | PRKD1 | 0.78818798 |
| 79 | UHMK1 | 0.78565139 |
| 80 | CDK14 | 0.78353039 |
| 81 | MAP3K6 | 0.77872863 |
| 82 | MAP2K1 | 0.77826157 |
| 83 | MAPKAPK5 | 0.77745802 |
| 84 | CDK18 | 0.77675170 |
| 85 | PAK3 | 0.76855664 |
| 86 | ZAP70 | 0.75570723 |
| 87 | ROCK2 | 0.74958346 |
| 88 | MAP3K4 | 0.74615815 |
| 89 | CDK11A | 0.72665357 |
| 90 | PIM2 | 0.72477146 |
| 91 | PTK2 | 0.72076920 |
| 92 | DAPK1 | 0.70293146 |
| 93 | PKN2 | 0.70117610 |
| 94 | PKN1 | 0.70031914 |
| 95 | FGR | 0.69165628 |
| 96 | MAP3K10 | 0.68775456 |
| 97 | FYN | 0.67840517 |
| 98 | CAMKK2 | 0.67557879 |
| 99 | TNK2 | 0.67486937 |
| 100 | SIK1 | 0.65372752 |
| 101 | CAMK1 | 0.64940265 |
| 102 | MET | 0.64242389 |
| 103 | CAMK2A | 0.64110811 |
| 104 | SGK1 | 0.63301891 |
| 105 | MAPK11 | 0.63238652 |
| 106 | CAMK1G | 0.62838307 |
| 107 | LIMK1 | 0.61905159 |
| 108 | TESK2 | 0.61293166 |
| 109 | MAP2K4 | 0.60748512 |
| 110 | IRAK2 | 0.60316750 |
| 111 | HCK | 0.59175823 |
| 112 | CAMK2G | 0.59164293 |
| 113 | SIK3 | 0.58822533 |
| 114 | PDGFRB | 0.57543241 |
| 115 | SGK3 | 0.56271591 |
| 116 | LATS2 | 0.56008209 |
| 117 | MAPKAPK3 | 0.55055307 |
| 118 | ABL2 | 0.54809668 |
| 119 | CDK19 | 0.54174472 |
| 120 | CAMK2D | 0.53677216 |
| 121 | PAK2 | 0.52252452 |
| 122 | HIPK2 | 0.51437559 |
| 123 | PTK6 | 0.51130084 |
| 124 | PINK1 | 0.49764929 |
| 125 | ILK | 0.48986766 |
| 126 | CDC42BPA | 0.48681195 |
| 127 | RPS6KA3 | 0.48225680 |
| 128 | MAP4K1 | 0.47909145 |
| 129 | PRKCG | 0.47732759 |
| 130 | LRRK2 | 0.47360560 |
| 131 | RPS6KL1 | 0.46368247 |
| 132 | RPS6KC1 | 0.46368247 |
| 133 | PRKCZ | 0.45627818 |
| 134 | MAP3K14 | 0.45563697 |
| 135 | MAP2K2 | 0.44509508 |
| 136 | PRKCQ | 0.44337677 |
| 137 | MAPK10 | 0.42998649 |
| 138 | SRC | 0.42463317 |
| 139 | CLK1 | 0.42451110 |
| 140 | TYK2 | 0.41454768 |
| 141 | MAPK12 | 0.41307994 |
| 142 | NEK6 | 0.40866006 |
| 143 | MAPK7 | 0.40478456 |
| 144 | MAP3K8 | 0.38332430 |
| 145 | TRPM7 | 0.37187619 |
| 146 | BRAF | 0.36561794 |
| 147 | MAPKAPK2 | 0.34882417 |
| 148 | CHUK | 0.32951393 |
| 149 | PAK1 | 0.30228340 |
| 150 | MAP2K6 | 0.29888250 |
| 151 | MELK | 0.29277284 |
| 152 | ROCK1 | 0.29213263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.84439340 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.81962923 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.52520330 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.15264884 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.02475002 |
| 6 | Cocaine addiction_Homo sapiens_hsa05030 | 2.01944299 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 1.93116501 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.92994794 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.92683881 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.84933066 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.80014009 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.79763249 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.76974908 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.69414115 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.67841590 |
| 16 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.66347395 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.63631007 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.60860134 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.59254127 |
| 20 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.58639472 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.58104585 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.49601640 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.49574045 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.47151097 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.46711499 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.45200352 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.43176234 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.39312645 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.37172887 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.36140138 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.35402013 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.34663285 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33042009 |
| 34 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.32814596 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.26081743 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22137642 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18021915 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.16958625 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.15883775 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.15460933 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12995440 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12637554 |
| 43 | Long-term depression_Homo sapiens_hsa04730 | 1.11199824 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10832288 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.10659869 |
| 46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.06776590 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06628164 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06298355 |
| 49 | Insulin secretion_Homo sapiens_hsa04911 | 1.03298349 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03032645 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.00730402 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99646506 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98482242 |
| 54 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.96379547 |
| 55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.95955975 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 0.95845686 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94903124 |
| 58 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93651352 |
| 59 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91721883 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 0.91473582 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.89824466 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.89422322 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88636015 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88253957 |
| 65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87813750 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87544997 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87088966 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.86951801 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86847708 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.85721410 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85168849 |
| 72 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84790267 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.84134597 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83934218 |
| 75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83537271 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.83137075 |
| 77 | Salmonella infection_Homo sapiens_hsa05132 | 0.82162285 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81619138 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81551369 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80680669 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.79917069 |
| 82 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79531434 |
| 83 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76182889 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76022828 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75264435 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74884820 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.74256014 |
| 88 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73935036 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73445273 |
| 90 | Melanogenesis_Homo sapiens_hsa04916 | 0.72621549 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.69838683 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.69186917 |
| 93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69041311 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.68024590 |
| 95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66856269 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66492448 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.66296163 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65989275 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65928688 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.63883693 |
| 101 | Focal adhesion_Homo sapiens_hsa04510 | 0.63165188 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62712005 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62654551 |
| 104 | Taste transduction_Homo sapiens_hsa04742 | 0.62650196 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62574452 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62460096 |
| 107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61510216 |
| 108 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61456416 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.61376117 |
| 110 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60935930 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60694314 |
| 112 | Malaria_Homo sapiens_hsa05144 | 0.60156992 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60120808 |
| 114 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59889421 |
| 115 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58832817 |
| 116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57921819 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57327050 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57102823 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56693742 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56462719 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54562542 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53492243 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52477854 |
| 124 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52287680 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51683933 |
| 126 | Hepatitis B_Homo sapiens_hsa05161 | 0.51601149 |
| 127 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51424718 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51078268 |
| 129 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50966396 |
| 130 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50169443 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50128235 |
| 132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49413008 |
| 133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48611491 |
| 134 | Bladder cancer_Homo sapiens_hsa05219 | 0.48321163 |
| 135 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47376081 |
| 136 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43367801 |
| 137 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41230663 |
| 138 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40368027 |
| 139 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39041149 |
| 140 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38699869 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.38214540 |
| 142 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38121609 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38042314 |
| 144 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37240891 |
| 145 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36642709 |
| 146 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34782879 |
| 147 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.33993596 |
| 148 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.33941650 |
| 149 | Lysosome_Homo sapiens_hsa04142 | 0.33048474 |

